Difference between revisions of "Team:SYSU-MEDICINE"

Line 232: Line 232:
 
             width: 332px;
 
             width: 332px;
 
             margin-top: 100px;
 
             margin-top: 100px;
 
+
            z-index: 2000;
 
         }
 
         }
  
Line 241: Line 241:
 
                 // do something...
 
                 // do something...
 
                 $("#wechatModal").after('<div class="modal-backdrop fade in"></div>');
 
                 $("#wechatModal").after('<div class="modal-backdrop fade in"></div>');
             })
+
             });
 +
            $(".modal").click(function() {
 +
//                console.log("click");
 +
                //$(this).remove();
 +
                $(".modal-backdrop").remove();
 +
                $('#wechatModal').modal('hide');
 +
            });
 +
           
 
         });
 
         });
 
     </script>
 
     </script>

Revision as of 16:03, 6 October 2016

MSCavalry

-----MSCs of
next generation

Inflammatory diseases are an increasing cause of disability and even fatality. Currently, apart from common treatments, MSCs therapy is a promising candidate for curing inflammatory diseases. However, intravascular injected MSCs are criticized for its low homing efficiency and ambiguous distribution in human body.

This year, MSCavalry: MSCs of next generation is coming. SYSU-MEDICINE decide to engineer a set of MSCs (homo sapiens) with higher accuracy and we hope that our project can pave the way for future MSCs clinical application.